Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection
Christina M. Arieta, Yushu Joy Xie, Daniel Rothenberg, et al.
Cell (2023) Vol. 186, Iss. 11, pp. 2392-2409.e21
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

An intranasal live-attenuated SARS-CoV-2 vaccine limits virus transmission
Julia M. Adler, Ricardo Martin Vidal, Christine Langner, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 15
A truncated pre-F protein mRNA vaccine elicits an enhanced immune response and protection against respiratory syncytial virus
Min Lin, Yifan Yin, Xiaomeng Zhao, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
The Immunogenicity of Coxsackievirus A6 (D3a Sub‐Genotype) Virus‐Like Particle and mRNA Vaccines
Huanhuan Lu, Jinbo Xiao, Jingdong Song, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 2
Closed Access | Times Cited: 1
Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history
Hailey Hornsby, Alexander R. Nicols, Stéphanie Longet, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 27
T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19
Reza Zonozi, Lucy C. Walters, Aaron Shulkin, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 724
Closed Access | Times Cited: 26
T cell immune memory after covid-19 and vaccination
Lulu Wang, Alexander R. Nicols, Lance Turtle, et al.
BMJ Medicine (2023) Vol. 2, Iss. 1, pp. e000468-e000468
Open Access | Times Cited: 25
Advanced technologies for the development of infectious disease vaccines
Akash Gupta, Arnab Rudra, Kaelan Reed, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 12, pp. 914-938
Closed Access | Times Cited: 7
Vaccine process technology—A decade of progress
Barry C. Buckland, Gautam Sanyal, Todd Ranheim, et al.
Biotechnology and Bioengineering (2024) Vol. 121, Iss. 9, pp. 2604-2635
Open Access | Times Cited: 6
The Key to Increase Immunogenicity of Next-Generation COVID-19 Vaccines Lies in the Inclusion of the SARS-CoV-2 Nucleocapsid Protein
Noe Juvenal Mendoza-Ramírez, Julio García‐Cordero, Gaurav Shrivastava, et al.
Journal of Immunology Research (2024) Vol. 2024, pp. 1-18
Open Access | Times Cited: 5
N-protein vaccine is effective against COVID-19: phase 3, randomized, double-blind, placebo-controlled clinical trial
Sevastyan O. Rabdano, Ellina Ruzanova, Anastasiya Evgenievna Vertyachikh, et al.
Journal of Infection (2024), pp. 106288-106288
Open Access | Times Cited: 5
Distinct CD8+ T-cell types Associated with COVID-19 Severity in Unvaccinated HLA-A2+ Patients
Kazuya Masuda, Sho Iketani, Lihong Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Characterising the SARS-CoV-2 nucleocapsid (N) protein antibody response
Charles O. Noble, Ellie McDonald, Suellen Nicholson, et al.
Journal of Infection (2025), pp. 106436-106436
Open Access
Combined immunization with SARS-CoV-2 spike and SARS-CoV nucleocapsid protects K18-hACE2 mice but increases lung pathology
Jae‐Kwan Kim, A. V. Kachko, Prabhuanand Selvaraj, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
Large‐Scale Screening of CD4+ T‐Cell Epitopes From SARS‐CoV‐2 Proteins and the Universal Detection of SARS‐CoV‐2 Specific T Cells for Northeast Asian Population
Yu Zhao, Chengtao He, Min Peng, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 2
Closed Access
Establishing correlation between in vitro potency and in vivo immunogenicity for mRNA vaccines
Gautam Sanyal
(2025)
Closed Access
Pan‐Variant SARS‐CoV‐2 Vaccines Induce Protective Immunity by Targeting Conserved Epitopes
Masaud Shah, Sung Ung Moon, Ji‐Yon Shin, et al.
Advanced Science (2025)
Open Access
T-Cell Epitope-Based Vaccines: A Promising Strategy for Prevention of Infectious Diseases
Xin Song, Yongfeng Li, Hongxia Wu, et al.
Vaccines (2024) Vol. 12, Iss. 10, pp. 1181-1181
Open Access | Times Cited: 4
UB-612 pan-SARS-CoV-2 T cell immunity-promoting vaccine protects against COVID-19 moderate-severe disease
Chang Yi Wang, Be-Sheng Kuo, Yu-Hsiang Lee, et al.
iScience (2024) Vol. 27, Iss. 2, pp. 108887-108887
Open Access | Times Cited: 3
The immunobiology of SARS-CoV-2 infection and vaccine responses: potential influences of cross-reactive memory responses and aging on efficacy and off-target effects
Craig Collins, Dan L. Longo, William J. Murphy
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
SARS-CoV-2 infection establishes a stable and age-independent CD8+ T cell response against a dominant nucleocapsid epitope using restricted T cell receptors
Cecily Choy, Joseph Chen, Jiangyuan Li, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Five doses of the mRNA vaccination potentially suppress ancestral-strain stimulated SARS-CoV2-specific cellular immunity: a cohort study from the Fukushima vaccination community survey, Japan
Yuta Tani, Morihito Takita, Masatoshi Wakui, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
A multi-epitope/CXCL11 prime/pull coronavirus mucosal vaccine boosts the frequency and the function of lung-resident memory CD4 + and CD8 + T cells and enhanced protection against COVID-19-like symptoms and death caused by SARS-CoV-2 infection
Latifa Zayou, Swayam Prakash, Nisha R. Dhanushkodi, et al.
Journal of Virology (2023) Vol. 97, Iss. 12
Open Access | Times Cited: 8
The HLA-II immunopeptidome of SARS-CoV-2
Shira Weingarten-Gabbay, Da‐Yuan Chen, Siranush Sarkizova, et al.
Cell Reports (2023) Vol. 43, Iss. 1, pp. 113596-113596
Open Access | Times Cited: 8
Integrating Machine Learning-Enhanced Immunopeptidomics and SARS-CoV-2 Population-Scale Analyses Unveils Novel Antigenic Features for Next-Generation COVID-19 Vaccines
Étienne Caron, Kevin A. Kovalchik, David Hamelin, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 2
Serological assessment of the durability of vaccine-mediated protection against SARS-CoV-2 infection
John T. Bates, Seth T. Lirette, Andrew P. Farmer, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top